Beth Sandy, CRNP

NPI: 1689735581
Total Payments
$708,588
2024 Payments
$195,622
Companies
17
Transactions
1,272
Medicare Patients
375
Medicare Billing
$66,157

Payment Breakdown by Category

Other$498,225 (70.3%)
Travel$161,489 (22.8%)
Food & Beverage$24,387 (3.4%)
Consulting$24,354 (3.4%)
Education$133.09 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $494,875 345 69.8%
Travel and Lodging $161,489 584 22.8%
Food and Beverage $24,387 320 3.4%
Consulting Fee $24,354 19 3.4%
Honoraria $3,350 2 0.5%
Education $133.09 2 0.0%

Top Paying Companies

Company Total Records Latest Year
AstraZeneca Pharmaceuticals LP $356,865 536 $0 (2024)
Amgen Inc. $102,685 229 $0 (2024)
JAZZ PHARMACEUTICALS INC. $102,248 233 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $75,000 111 $0 (2024)
Lilly USA, LLC $35,284 96 $0 (2024)
Merck Sharp & Dohme LLC $27,035 42 $0 (2024)
Janssen Biotech, Inc. $3,470 6 $0 (2024)
E.R. Squibb & Sons, L.L.C. $3,093 2 $0 (2022)
Janssen Scientific Affairs, LLC $1,055 2 $0 (2022)
PFIZER INC. $888.38 3 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $195,622 338 AstraZeneca Pharmaceuticals LP ($103,001)
2023 $193,440 372 AstraZeneca Pharmaceuticals LP ($93,837)
2022 $162,361 310 AstraZeneca Pharmaceuticals LP ($56,647)
2021 $157,166 252 AstraZeneca Pharmaceuticals LP ($103,380)

All Payment Transactions

1,272 individual payment records from CMS Open Payments — Page 1 of 51

Date Company Product Nature Form Amount Type
12/20/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging Cash or cash equivalent $79.07 General
12/20/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging Cash or cash equivalent $38.00 General
12/20/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging Cash or cash equivalent $33.50 General
12/20/2024 AstraZeneca Pharmaceuticals LP Food and Beverage Cash or cash equivalent $20.08 General
12/20/2024 AstraZeneca Pharmaceuticals LP Food and Beverage Cash or cash equivalent $16.63 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $51.65 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $33.50 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $32.00 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $29.48 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $28.00 General
12/19/2024 Lilly USA, LLC Travel and Lodging Cash or cash equivalent $6.00 General
12/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,000.00 General
Category: ONCOLOGY
12/18/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging In-kind items and services $288.21 General
12/18/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $111.49 General
12/18/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Travel and Lodging Cash or cash equivalent $75.00 General
Category: ONCOLOGY
12/17/2024 Lilly USA, LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General
12/17/2024 Lilly USA, LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,050.00 General
12/12/2024 Lilly USA, LLC Travel and Lodging In-kind items and services $380.72 General
12/12/2024 Lilly USA, LLC Travel and Lodging In-kind items and services $238.92 General
12/12/2024 Lilly USA, LLC Travel and Lodging In-kind items and services $184.30 General
12/12/2024 Lilly USA, LLC Food and Beverage Cash or cash equivalent $90.16 General
12/11/2024 JAZZ PHARMACEUTICALS INC. ZEPZELCA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $230.00 General
Category: HEMATOLOGY/ONCOLOGY
12/11/2024 AstraZeneca Pharmaceuticals LP Travel and Lodging In-kind items and services $208.47 General
12/11/2024 AstraZeneca Pharmaceuticals LP Food and Beverage In-kind items and services $102.29 General
12/10/2024 Lilly USA, LLC Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,200.00 General

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 56 165 $31,558 $12,079
2022 3 101 251 $37,462 $17,686
2021 3 117 277 $41,398 $20,050
2020 2 101 259 $44,135 $16,342
Total Patients
375
Total Services
952
Medicare Billing
$66,157
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 34 124 $20,522 $8,041 39.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2023 22 41 $11,036 $4,038 36.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 53 168 $23,520 $11,329 48.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Facility 2022 27 49 $10,780 $4,778 44.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 21 34 $3,162 $1,578 49.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 67 203 $28,420 $13,917 49.0%
99215 Established patient outpatient visit, total time 40-54 minutes Facility 2021 32 48 $10,560 $4,953 46.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 18 26 $2,418 $1,179 48.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Facility 2020 51 180 $25,700 $10,243 39.9%
99215 Established patient office or other outpatient, visit typically 40 minutes Facility 2020 37 53 $11,660 $4,082 35.0%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 13 26 $6,775 $2,017 29.8%

About Beth Sandy, CRNP

Beth Sandy, CRNP is a Adult Health healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689735581.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Beth Sandy, CRNP has received a total of $708,588 in payments from pharmaceutical and medical device companies, with $195,622 received in 2024. These payments were reported across 1,272 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($494,875).

As a Medicare-enrolled provider, Sandy has provided services to 375 Medicare beneficiaries, totaling 952 services with total Medicare billing of $66,157. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Adult Health
  • Location Philadelphia, PA
  • Active Since 12/13/2006
  • Last Updated 08/10/2011
  • Taxonomy Code 363LA2200X
  • Entity Type Individual
  • NPI Number 1689735581

Products in Payments

  • TAGRISSO (Drug) $198,330
  • IMFINZI (Biological) $141,705
  • ZEPZELCA (Drug) $102,248
  • LUMAKRAS (Drug) $73,761
  • ALUNBRIG (Drug) $44,773
  • EXKIVITY (Drug) $30,148
  • KEYTRUDA (Biological) $23,244
  • RYBREVANT (Drug) $3,776
  • FIRDAPSE (Drug) $350.00
  • LORBRENA (Drug) $168.38
  • KRAZATI (Drug) $124.99
  • OPDIVO (Biological) $93.31
  • DARZALEX (Biological) $69.44
  • Alecensa (Biological) $46.55
  • Optune (Device) $45.01
  • IMDELLTRA (AMG 757) (Biological) $42.38
  • Optune Lua (NovoTTF-200T) (Device) $34.52
  • GILOTRIF (Drug) $31.08
  • CoolSeal Generator (Device) $14.18

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Adult Health Doctors in Philadelphia